This report contains market size and forecasts of Endocrine Therapy Drugs (ETDs) in global, including the following market information:
Global Endocrine Therapy Drugs (ETDs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Endocrine Therapy Drugs (ETDs) Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Endocrine Therapy Drugs (ETDs) companies in 2021 (%)
The global Endocrine Therapy Drugs (ETDs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidiabetic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endocrine Therapy Drugs (ETDs) include Novo Nordisk, AstraZeneca, Generex Biotechnology, Sanofi, MSD, Pfizer, Huadong Medicine, Bayer and Tonghua Dongbao Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Endocrine Therapy Drugs (ETDs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endocrine Therapy Drugs (ETDs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Endocrine Therapy Drugs (ETDs) Market Segment Percentages, by Type, 2021 (%)
Antidiabetic Drugs
Anti-osteoporosis Drugs
Contraceptive
Other
Global Endocrine Therapy Drugs (ETDs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Endocrine Therapy Drugs (ETDs) Market Segment Percentages, by Application, 2021 (%)
Diabetes Treatment
Osteoporosis Treatment
Contraception
Other
Global Endocrine Therapy Drugs (ETDs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Endocrine Therapy Drugs (ETDs) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endocrine Therapy Drugs (ETDs) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Endocrine Therapy Drugs (ETDs) revenues share in global market, 2021 (%)
Key companies Endocrine Therapy Drugs (ETDs) sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Endocrine Therapy Drugs (ETDs) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
AstraZeneca
Generex Biotechnology
Sanofi
MSD
Pfizer
Huadong Medicine
Bayer
Tonghua Dongbao Pharmaceutical